The WHO also made a conditional recommendation for the use of the monoclonal antibody sotrovimab in patients with non-severe Covid-19, but only in those at highest risk of hospitalisation, reflecting trivial benefits in those at lower risk.
Fenofibrate, which is approved for use by most countries in the world including the US Food and Drug Administration (FDA) and the UK's National Institute for Health and Care Excellence (NICE), is an oral drug currently used to treat conditions such as high levels of cholesterol and lipids (fatty substances) in the blood.
Roche India on Monday announced the rollout of its first batch of the antibody cocktail (Casirivimab and Imdevimab) against Coronavirus in India. The cocktail drug will be marketed by Cipla pan-India.
Bhubaneswar: The Directorate of Drugs Control, Odisha today allowed the retail sale of Covid-19 drugs Remdesivir and Fevipiravir as per the directives of the Drugs Controller General India (DCGI). However, both the COVID drugs will be sold on certain conditions. DCGI has directed that the Fevipiravir tablets and Remdesivir injectable formulation will be sold under […]